Revolo Biotherapeutics Presents New Data on '1805 at the American College of Rheumatology Convergence 2023 Annual Conference tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Revolo Biotherapeutics to Host Virtual KOL Event on '1104: A First-in-Class Peptide for Eosinophilic Esophagitis (EoE) and Allergic Disease tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Revolo Biotherapeutics Announces Additional Data from Phase 2a Trial of '1104 in Adults with Active Eosinophilic Esophagitis itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.